Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
11/1995
11/09/1995WO1995030001A2 Novel p-selectin ligand protein
11/09/1995WO1995030000A1 Dna sequences
11/09/1995WO1995029999A2 A process for separating milk clotting enzymes, and stable rennet compositions
11/09/1995WO1995029998A1 Thermostable xylanases
11/09/1995WO1995029997A1 Use of a thermostable enzyme as a feed additive
11/09/1995WO1995029996A1 Alkaline glucose oxidase
11/09/1995WO1995029979A1 Fabric cleaning compositions containing subtilisin bpn' variants
11/09/1995DE4440118C1 Die Genexpression in coryneformen Bakterien regulierende DNA Gene expression in coryneform bacteria regulatory DNA
11/09/1995CA2189543A1 Thymidine kinase mutants
11/09/1995CA2189542A1 Alkaline glucose oxidase
11/09/1995CA2189438A1 Dna sequences
11/09/1995CA2189428A1 Fabric cleaning compositions containing subtilisin bpn' variants
11/09/1995CA2189056A1 Improvements in or relating to disease-resistance of plants
11/09/1995CA2188558A1 Use of a thermostable enzyme as a feed additive
11/09/1995CA2186365A1 Neural receptor tyrosine kinase
11/08/1995EP0680764A2 Stable preparation for the treatment of blood coagulation disorders, comprising an activated coagulation factor and lipid vesicles
11/08/1995EP0680763A2 Stable preparation for the treatment of blood coagulation disorders comprising an activated coagulation factor and lipid vesicles
11/08/1995EP0680511A1 Acetyl-coa-carboxylase-gene
11/08/1995EP0680510A1 Enzyme containing granulate, method for production thereof, and use thereof
11/08/1995EP0680333A1 Prevention and treatment of cytomegalovirus using aminopeptidase
11/08/1995EP0680316A1 Novel parasitic helminth proteins
11/08/1995EP0425572B1 Uses of viral enzymes
11/08/1995EP0419574B1 Monoclonal antibodies to the light chain region of human factor xii and methods of preparing and using the same
11/08/1995EP0373181B1 Novel coenzyme independent l-sorbosone dehydrogenase
11/08/1995EP0306496B1 Method for reducing the toxicity of lps and method for detoxifying an lps-containing therapeutic liquid
11/08/1995CN1111455A Peptide inhibitors of mitogenesis and motorgenesis
11/08/1995CN1111285A Transesterification method with powdery lipase
11/08/1995CN1111229A Enzymatic hydrolysis method for the conversion of C-7 sugar to C-7 hydroxyl taxanes
11/08/1995CN1111112A Method for deactivating enzymes and microorganisms
11/07/1995US5464863 Anticholesterol agents
11/07/1995US5464822 Polypeptides and polypeptide analogues
11/07/1995US5464818 From clostridium
11/07/1995US5464768 Genetic engineering
11/07/1995US5464766 Multienzyme powdered composition containing bacteria for treatment of waste
11/07/1995US5464764 Method for enriching transformed murine embryonic stem cell containing modification in target DNA sequence in genome of cell
11/07/1995US5464751 Purified protein or fragment bindable with p185, translation product of neu oncogene; dimer or trimer of protein; screening for mammalian tumor with p185 on tumor cell surfaces by contacting cells with protein, detecting bound protein
11/07/1995US5464747 Oxidation-resistant muteins of β-galactosidase fragments
11/07/1995US5464744 Methods and compositions for reducing false positive signals in an RNA amplification system
11/07/1995US5464615 Use of transglutaminases as immunosuppressants
11/07/1995US5464614 Stabilized superoxide dismutase (SOD) composition
11/07/1995CA2148746A1 Stable preparation for the treatment of blood coagulation disorders
11/07/1995CA2148672A1 Stable preparation for the treatment of blood coagulation disorders comprising an active coagulation promoting substance
11/02/1995WO1995029259A1 Method and means for detecting and treating disorders in the blood coagulation cascade
11/02/1995WO1995029256A1 Chondroitinases i and ii, methods of preparation, and use thereof
11/02/1995WO1995029253A1 Dna encoding cephamycin biosynthesis late enzymes
11/02/1995WO1995029246A1 Plant gene specifying acetyl coenzyme a carboxylase and transformed plants containing same
11/02/1995WO1995029242A1 Angiostatin and method of use for inhibition of angiogenesis
11/02/1995WO1995029233A1 ISOLATED NUCLEIC ACID MOLECULE CODING FOR FIBROBLAST ACTIVATION PROTEIN α AND USES THEREOF
11/02/1995WO1995029232A1 Chondroitinase ii and its use with chondroitinase i to achieve complete vitreal disinsertion
11/02/1995WO1995029224A1 Amylase-containing detergent compositions
11/02/1995WO1995029223A1 Naphthalene boronic acids
11/02/1995WO1995029192A1 Thymidine kinase tk1, peptide, corresponding antibodies and use of these in determination of tumor proliferation
11/02/1995WO1995029187A1 Chromatographic process for the copurification of chondroitinase i and ii proteins
11/02/1995WO1995029185A1 Novel megakaryocytic protein tyrosine kinases
11/02/1995WO1995029150A1 Synthesis of prototypes for renin inhibitors
11/02/1995WO1995028955A1 PEPTIDES BINDING TO THE α2-MACROGLOBULIN RECEPTOR/LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN
11/02/1995EP0679334A2 Fungistatic composition and a fungistatic method utilizing the composition
11/02/1995EP0679189A1 Cloning of enterokinase and method of use
11/02/1995EP0679188A1 Modified cutinases, dna, vector and host
11/02/1995EP0679184A1 Periplasmic 3':5'-cyclic nucleotide phosphodiesterase and related methods for producing and using the same
11/02/1995EP0679183A1 Enhancement of enzyme reactions
11/02/1995EP0404967B1 Recombinant c-terminal alpha-amidating enzyme of human thyroid origin
11/02/1995CA2189012A1 Naphthalene boronic acids
11/02/1995CA2188403A1 Amylase-containing detergent compositions
11/02/1995CA2188257A1 Dna encoding cephamycin biosynthesis late enzymes
11/02/1995CA2188159A1 Chondroitinases i and ii, methods of preparation, and use thereof
10/1995
10/31/1995US5463175 Glyphosate tolerant plants
10/31/1995US5463107 Useful in prophylaxis and treatment of diseases caused by excessive secretion of endothelin
10/31/1995US5463028 Compound comprising a methyl ecgonine group chemically attached to a phenylphosphonic group which is an analog to an intermediate of the hydrolysis transition-state of a cocaine benzoyl ester group
10/31/1995US5463025 Protein having human plasmin inhibiting activity
10/31/1995US5462869 Human endothelin converting enzyme isolated from blood or placenta by hydrated density
10/31/1995US5462868 Cocaine esterase from Pseudomonas sp. NCIMB 40427 for detection of cocaine
10/31/1995US5462862 Antibiotics from microorganisms
10/31/1995US5462861 Method for improving enzyme activities with noble gases
10/31/1995CA2002516C Process for the expression of a recombinant gene
10/30/1995CA2122874A1 Neural receptor tyrosine kinase
10/26/1995WO1995028498A1 Method for molecular staging of prostate cancer
10/26/1995WO1995028493A1 Aav-mediated delivery of dna to cells of the nervous system
10/26/1995WO1995028489A1 Dihydropyrimidine dehydrogenase compositions and methods of use
10/26/1995WO1995028484A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995WO1995028483A1 Cell-cycle regulatory proteins, and uses related thereto
10/26/1995WO1995028476A1 Recombinant zymomonas for pentose fermentation
10/26/1995WO1995028422A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
10/26/1995WO1995028421A1 Method and product for regulating cell responsiveness to external signals
10/26/1995WO1995028412A1 α(1,3) GALACTOSYLTRANSFERASE NEGATIVE SWINE
10/26/1995WO1995028092A1 Stable water-in-oil emulsions
10/26/1995WO1995027047A3 Highly-purified recombinant reverse transcriptase
10/26/1995DE4447484A1 APO-1 inhibitor compsn. inhibits apoptosis
10/26/1995CA2189028A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995CA2188180A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
10/26/1995CA2187802A1 .alpha.(1,3) galactosyltransferase negative swine
10/26/1995CA2187775A1 Method for molecular staging of prostate cancer
10/26/1995CA2186639A1 Cell-cycle regulatory proteins, and uses related thereto
10/25/1995EP0678576A2 Fructosyl amino acid oxidase and process for producing the same
10/25/1995EP0678508A1 Indoles as inhibitors of HIV reverse transcriptase
10/25/1995EP0678121A1 Methods and reagents for inhibiting furin endoprotease
10/25/1995EP0433378B1 ALLELIC VARIANTS OF $i(PLASMODIUM FALCIPARUM) MEROZOITE SURFACE ANTIGEN
10/24/1995US5461143 Oligosaccharide enzyme substrates and inhibitors: methods and compositions
10/24/1995US5460961 Human myeloperoxidase and its therapeutic application
10/24/1995US5460960 Isolating antibodies produced by a hapten similar to both the reactant and catalyst; modifying these antibodies by binding a converting hapten for the reactant/actual catalyst complex
1 ... 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 ... 1416